|
Molecular properties generated using the CDK |
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
butyl 2-[(6aR,9R,10aR)-1-hydroxy-9-(hydroxymethyl)-6,6-dimethyl-6H,6aH,7H,8H,9H,10H,10aH-benzo[c]isochromen-3-yl]-2-methylpropanoate |
Synonyms ![]() |
compound 3b [PMID: 27367336] |
Database Links ![]() |
|
GtoPdb PubChem SID | 315661332 |
PubChem CID | 121231416 |
Search Google for chemical match using the InChIKey | OSVHLUXLWQLPIY-KBAYOESNSA-N |
Search Google for chemicals with the same backbone | OSVHLUXLWQLPIY |
Search UniChem for chemical match using the InChIKey | OSVHLUXLWQLPIY-KBAYOESNSA-N |
Search UniChem for chemicals with the same backbone | OSVHLUXLWQLPIY |
Comments |
AM7499 is a non-selective cannabinoid receptor agonist [1]. It has been designed to be readily hydrolysed by plasma esterases (to shorten its duration of action; such compounds are being called 'controlled-deactivation cannabinoids') and to be less prone to deposition in bodily fat than existing classical cannabinoid agonists. This strategy has been adopted to produce cannabinoid agonists with improved drug-like qualities and potentially a more favourable safety profile. |